跳至主要内容
临床试验/JPRN-UMIN000035298
JPRN-UMIN000035298已完成未知

A verification study for the effect of the food containing plant-derived ingredients intake on uric acid level: a randomized, double-blind, placebo-controlled, parallel-group trial - A verification study for the effect of the food containing plant-derived ingredients intake on uric acid level

ORTHOMEDICO Inc.0 个研究点目标入组 166 人开始时间: 2019年9月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
166

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, hyperuricemia, obesity (based on the standard definition by the Japan Society for the Study of Obesity), or any other chronic diseases 4. Subjects who have had symptoms of gout 5. Subjects who work late-night shift or are irregular of their life-styles 6. Subjects who excessively exercise 7. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional foods/beverages in daily 8. Subjects who are currently taking medications (including herbal medicines) and supplement. Particularly, diosmin, anticoagulant drugs, antiplatelet drugs, antihypertensive drugs (celiprolol hydrochloride, diltiazem hydrochloride, and etc.), diazepam, central nervous system depressant, and vasodilator drugs (verapamil) 9. Subjects who are an allergic reaction to medications and/or products that contain the study ingredients, particularly citrus. 10. Subjects who are pregnant, lactation, or planning to become pregnant 11. Subjects who have been enrolled in another clinical study within the last three months prior to signing informed consent for the current study or plan to enroll in anther clinical study during study period 12. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician

研究者

相似试验